RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes

Faizan H. Khan, Vijayabaskar Pandian, Satish Kumar Ramraj, Sheeja Aravindan, Mohan Natarajan, Seifollah Azadi, Terence S. Herman, Natarajan Aravindan

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences